Company Information
USD
12.79
- (4.4%)
NASDAQ:QURE, UNIQURE N.V.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Address
Paasheuvelweg 25
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Jack L. Kaye
Director
Dr. Leonard E. Post, PhD
Director
Mr. Matthew C. Kapusta
CEO/Director
Mr. David D. Meek
Chairman of the Board/Director
Ms. Paula Soteropoulos
Director
Mr. Madhavan Balachandran
Director
Mr. Christian Klemt
CFO/Chief Accounting Officer/General Manager, Subsidiary
Dr. Jeremy P. Springhorn, PhD
Director
Dr. Robert Gut, M.D.,PhD
Director
Ms. Rachelle Jacques
Director
Dr. Richard Porter, PhD
Chief Scientific Officer/Other Executive Officer
Mr. Pierre Caloz
COO
Ownership
Institution Holdings
Nantahala Capital Management, LLC
5,916,054 (12.367%)
SSGA Funds Management Inc
3,538,827 (7.397%)
State Street Corporation
3,478,872 (7.272%)
FMR LLC
2,700,927 (5.649%)
PFM Health Sciences, LP
2,302,314 (4.815%)
BlackRock Inc
1,836,696 (3.839%)
Morgan Stanley - Brokerage Accounts
1,759,818 (3.679%)
683 Capital Management LLC
1,693,000 (3.539%)
Goldman Sachs Group Inc
1,390,690 (2.907%)
Orbimed Advisors, LLC
1,347,900 (2.818%)
Individual Holdings
Mr. Matthew C. Kapusta
590,839 (1.235%)
Mr. Christian Klemt
166,448 (0.348%)
Mr. Jonathan Garen
93,638 (0.299%)
Mr. Pierre Caloz
118,643 (0.248%)
Mr. Walid Abi-Saab
116,700 (0.244%)
Dr. Robert Gut, M.D.,PhD
47,669 (0.100%)
Mr. Jack L. Kaye
34,119 (0.072%)
Dr. Jeremy P. Springhorn, PhD
25,987 (0.055%)
Mr. David D. Meek
22,481 (0.047%)
Ms. Paula Soteropoulos
22,423 (0.047%)
Funds Holdings
SPDR® S&P Biotech ETF
3,462,869 (7.239%)
Vanguard Institutional Extnd Mkt Idx Tr
661,919 (1.384%)
Columbia Small Cap Value Fund I
532,360 (1.113%)
AlphaCentric LifeSci Healthcare Fund
421,025 (0.880%)
iShares Biotechnology ETF
325,052 (0.679%)
Columbia VP Small Cap Value Fund
209,430 (0.438%)
Vanguard Health Care Index Fund
145,659 (0.304%)
BlackRock Extended Equity Market
107,056 (0.224%)
North Square Dynamic Small Cap Fd
96,010 (0.201%)
Fidelity Total Market Index Fund
79,824 (0.167%)
Make Smart Investment Choices